SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 14th, 2024 • Unicycive Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 14th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 13, 2024, by and among Unicycive Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).